OJRA  Vol.6 No.4 , November 2016
Cyanocobalamin and 25-Hydroxy Vitamin D Levels in Gout Patients: An Overlooked Issue
Gout is one of the most frequent type of inflammatory arthritis in developed countries. The elevation of serum uric acid levels and the deposition of monosodium urate crystals in joints and/or soft tissues are the mechanisms of pathogenesis. Uric acid is a product of the metabolic cleavage of purine nucleotides and organ meats, beef, pork, and lamb, anchovies, sardines, herring, mackerel, scallops, gravy and beer are known to be very rich in purine. On the other hand, some of these foods are also the main sources of vitamin B12 (cyanocobalamin). As a chronic inflammatory arthritis corticosteroids are frequently prescribed for gout patients, meaning a higher risk for osteoporosis which may be blocked by daily calcium and vitamin D replacement. However, there are no recommendations about screening or replacement of Gout patients for vitamin D and B12. Herein, we evaluated our patients retrospectively to document their vitamin levels and also to find the factors associated with vitamin deficiency. Totally, 90 patients, 71 (79.9%) male and 19 (20.1%) female patients with a median diagnostic age of 55 (19 - 80) were included. Thirty six (40%) patients were newly diagnosed (group 1) but 54 (60%) patients had established diseases (group-2) with median disease duration of 36 (11-240) months. Nearly half (47.2%) of the patients in group-1 and 37% of the patients in group-2 had vitamin B 12 deficiency. Similarly, 38.9% in each group had vitamin D deficiency and 52.8% in group-1 and 44.4% in group-2 had vitamin D insufficiency. In conclusion, we strongly recommend routine screening and replacement of vitamin B12 and D for patients with Gout.
Cite this paper
Yandı, Y. , Gencer, E. , Kılavuz, B. , Baki, A. , Şahin, H. , Bilici, M. , Işık, M. and Alışkan, T. (2016) Cyanocobalamin and 25-Hydroxy Vitamin D Levels in Gout Patients: An Overlooked Issue. Open Journal of Rheumatology and Autoimmune Diseases, 6, 96-101. doi: 10.4236/ojra.2016.64015.
[1]   Kuo, C.F., Grainge, M.J., See, L.C., Yu, K.H., Luo, S.F., Zhang, W. and Doherty, M. (2015) Epidemiology and Management of Gout in Taiwan: A Nationwide Population Study. Arthritis Research & Therapy, 17, 13.

[2]   Karis, E., Crittenden, D.B. and Pillinger, M.H. (2014) Hyperuricemia, Gout, and Related Comorbidities: Cause and Effect on a Two-Way Street. Southern Medical Association, 107, 235-241.

[3]   Papavasileiou, M.V., Karamanou, A.G., Kalogeropoulos, P., Moustakas, G., Patsianis, S. and Pittaras, A. (2015) Uric Acid Blood Levels and Relationship with the Components of Metabolic Syndrome in Hypertensive Patients. Journal of Human Hypertension, 30, 414-417.

[4]   Issac, T.G., Soundarya, S., Christopher, R. and Chandra, S.R. (2015) Vitamin B12 Deficiency: An Important Reversible Co-Morbidity in Neuropsychiatric Manifestations. Indian Journal of Psychological Medicine, 37, 26-29.

[5]   Ferrand, A., Siu, V.M., Rupar, C.A., Napier, M.P., Al-Dirbashi, O.Y., Chakraborty, P. and Prasad, C. (2015) Biochemical and Hematologic Manifestations of Gastric Intrinsic Factor (GIF) Deficiency: A Treatable Cause of B12 Deficiency in the Old Order Mennonite Population of Southwestern Ontario. JIMD Reports, 18, 69-77.

[6]   Khanna, D., Fitzgerald, J.D., Khanna, P.P., Bae, S., Singh, M.K., Neogi, T., Pillinger, M.H., Merill, J., Lee, S., Prakash, S., Kaldas, M., Gogia, M., Perez – Ruiz, F., Taylor, W., Lioté, F., Choi, H., Singh, J.A., Dalbeth, N., Kaplan, S., Niyyar, V., Jones, D., Yarows, S.A., Roessler, B., Kerr, G., King, C., Levy, G., Furst, D.E., Edwards, N.L., Mandell, B., Schumacher, H.R., Robbins, M., Wenger, N. and Terkeltaub, R. (2012) 2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia. Arthritis Care & Research (Hoboken), 64, 1431-1446.

[7]   Antony, A.C. (2005) Megaloblastic Anemias. In: Hoffman, R., Benz, E.J., Shattil, S.J., et al., Eds., Hematology: Basic Principles and Practice, 4th Edition, Churchill Livingstone, New York, 519.

[8]   Carvalho, L.S. and Sposito, A.C. (2015) Vitamin D for the Prevention of Cardiovascular Disease: Are We Ready for That? Atherosclerosis, 241, 729-740.

[9]   Andrés, M., Sivera, F., Falzon, L., Buchbinder, R. and Carmona, L. (2014) Dietary Supplements for Chronic Gout. Cochrane Database of Systematic Reviews, 10, Article ID: CD010156.

[10]   Dalvi, S.R. and Pillinger, M.H. (2013) Saturnine Gout, Redux: A Review. The American Journal of Medicine, 126, 450.e1-450.e8.

[11]   Mody, G.M. and Brooks, P.M. (2012) Improving Musculoskeletal Health: Global Issues. Best Practice & Research: Clinical Rheumatology, 26, 237-249.